Skip to main content
Erschienen in: European Radiology 5/2017

03.08.2016 | Magnetic Resonance

Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model

verfasst von: Wei Zhang, Hui Juan Chen, Zhen J. Wang, Wei Huang, Long Jiang Zhang

Erschienen in: European Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate whether dynamic contrast -enhanced MRI (DCE-MRI) can distinguish the type of liver nodules in a rat model with N-nitrosodiethylamine- induced cirrhosis.

Methods

Liver nodules in cirrhosis were induced in 60 male Wistar rats via 0.01 % N-nitrosodiethylamine in the drinking water for 35-100 days. The nodules were divided into three groups: regenerative nodule (RN), dysplastic nodule (DN), and hepatocellular carcinoma (HCC). DCE-MRI was performed, and parameters including transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve), and initial area under the contrast concentration versus time curve (iAUC) were measured and compared.

Results

The highest Ktrans and iAUC values were seen in HCC, followed by DN and RN (all P < 0.05). The area under the receiver operating characteristic curve (AUROC) for DN and HCC were 0.738 and 0.728 for Ktrans and iAUC, respectively. The AUROC for HCC were 0.850 and 0.840 for Ktrans and iAUC, respectively. Ordinal logistic regression analysis showed that Ktrans had a high goodness of fit (0.970, 95 % confidence interval, 13.751-24.958).

Conclusion

DCE-MRI is a promising method to differentiate of liver nodules. Elevated Ktrans suggested that the nodules may be transformed into HCC.

Key points

DCE-MRI is promising for differentiating among RN, DN, and HCC
K trans and iAUC positively correlated with malignancy degree of liver nodules
Elevated K trans suggests that the nodules may be transformed into HCC
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008. Int J Cancer 127:2893–2917CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008. Int J Cancer 127:2893–2917CrossRefPubMed
2.
3.
Zurück zum Zitat Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30:3–16CrossRefPubMed Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30:3–16CrossRefPubMed
4.
Zurück zum Zitat Alazawi W, Cunningham M, Dearden J, Foster GR (2010) Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther 32:344–355CrossRefPubMed Alazawi W, Cunningham M, Dearden J, Foster GR (2010) Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther 32:344–355CrossRefPubMed
5.
Zurück zum Zitat International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664CrossRef International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664CrossRef
6.
Zurück zum Zitat Kim YS, Song JS, Lee HK, Han YM (2015) Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation. Eur Radiol Kim YS, Song JS, Lee HK, Han YM (2015) Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation. Eur Radiol
7.
Zurück zum Zitat Song KD, Kim SH, Lim HK, Jung SH, Sohn I, Kim HS (2015) Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging. Eur Radiol 25:2789–2796CrossRefPubMed Song KD, Kim SH, Lim HK, Jung SH, Sohn I, Kim HS (2015) Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging. Eur Radiol 25:2789–2796CrossRefPubMed
8.
Zurück zum Zitat Tajima T, Honda H, Taguchi K et al (2002) Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 178:885–897CrossRefPubMed Tajima T, Honda H, Taguchi K et al (2002) Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 178:885–897CrossRefPubMed
9.
Zurück zum Zitat Matsui O, Kobayashi S, Sanada J et al (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264–272CrossRefPubMedPubMedCentral Matsui O, Kobayashi S, Sanada J et al (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264–272CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRefPubMed Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662CrossRefPubMed
11.
Zurück zum Zitat Hayashi M, Matsui O, Ueda K et al (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AIR Am J Roentgenol 172:969–976CrossRef Hayashi M, Matsui O, Ueda K et al (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AIR Am J Roentgenol 172:969–976CrossRef
12.
Zurück zum Zitat Boss MK, Muradyan N, Thrall DE (2013) DCE-MRI: a review and applications in veterinary oncology. Vet Comp Oncol 11:87–100CrossRefPubMed Boss MK, Muradyan N, Thrall DE (2013) DCE-MRI: a review and applications in veterinary oncology. Vet Comp Oncol 11:87–100CrossRefPubMed
13.
Zurück zum Zitat Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed
14.
Zurück zum Zitat Leach MO, Morgan B, Tofts PS et al (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22:1451–1464CrossRefPubMed Leach MO, Morgan B, Tofts PS et al (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22:1451–1464CrossRefPubMed
15.
Zurück zum Zitat Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186–192PubMed Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186–192PubMed
16.
Zurück zum Zitat Hötker AM, Mazaheri Y, Zheng J et al (2015) Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. Eur Radiol 25:2665–2672CrossRefPubMedPubMedCentral Hötker AM, Mazaheri Y, Zheng J et al (2015) Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. Eur Radiol 25:2665–2672CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Miyazaki K, Jerome NP, Collins DJ et al (2015) Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol 25:2641–2650CrossRefPubMedPubMedCentral Miyazaki K, Jerome NP, Collins DJ et al (2015) Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol 25:2641–2650CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hsu CY, Shen YC, Yu CW et al (2011) Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. J Hepatol 55:858–865CrossRefPubMed Hsu CY, Shen YC, Yu CW et al (2011) Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. J Hepatol 55:858–865CrossRefPubMed
19.
Zurück zum Zitat O’Connor JP, Jackson A, Parker GJ et al (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 9:167–177CrossRefPubMed O’Connor JP, Jackson A, Parker GJ et al (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 9:167–177CrossRefPubMed
20.
Zurück zum Zitat Barnes SL, Whisenant JG, Loveless ME et al (2012) Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics 4:442–478CrossRefPubMedPubMedCentral Barnes SL, Whisenant JG, Loveless ME et al (2012) Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics 4:442–478CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Aryal MP, Nagaraja TN, Keenan KA et al (2014) Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T. Magn Reson Med 71:2206–2214CrossRefPubMed Aryal MP, Nagaraja TN, Keenan KA et al (2014) Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T. Magn Reson Med 71:2206–2214CrossRefPubMed
22.
Zurück zum Zitat Nasui OC, Chan MW, Nathanael G et al (2014) Physiologic characterization of inflammatory arthritis in a rabbit model with BOLD and DCE MRI at 1.5 Tesla. Eur Radiol 24:2766–2778CrossRefPubMed Nasui OC, Chan MW, Nathanael G et al (2014) Physiologic characterization of inflammatory arthritis in a rabbit model with BOLD and DCE MRI at 1.5 Tesla. Eur Radiol 24:2766–2778CrossRefPubMed
23.
Zurück zum Zitat Thukral A, Thomasson DM, Chow CK et al (2007) Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--Initial experience. Radiology 244(3):727–735CrossRefPubMed Thukral A, Thomasson DM, Chow CK et al (2007) Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--Initial experience. Radiology 244(3):727–735CrossRefPubMed
24.
Zurück zum Zitat Mross K, Fasol U, Frost A et al (2009) DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study. J Angiogenes Res 1:5CrossRefPubMedPubMedCentral Mross K, Fasol U, Frost A et al (2009) DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study. J Angiogenes Res 1:5CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hahn OM, Yang C, Medved M et al (2008) Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 26:4572–4578CrossRefPubMedPubMedCentral Hahn OM, Yang C, Medved M et al (2008) Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 26:4572–4578CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335–350CrossRefPubMed Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335–350CrossRefPubMed
27.
Zurück zum Zitat Jarnagin WR, Schwartz LH, Gultekin DH et al (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20:1589–1595CrossRefPubMedPubMedCentral Jarnagin WR, Schwartz LH, Gultekin DH et al (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20:1589–1595CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Hirashima Y, Yamada Y, Tateishi U et al (2012) Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis. Int J Cancer 130:2359–2365CrossRefPubMed Hirashima Y, Yamada Y, Tateishi U et al (2012) Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis. Int J Cancer 130:2359–2365CrossRefPubMed
29.
Zurück zum Zitat Xu H, Xie JX, Li X et al (2008) Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model. J Magn Reson Imaging 27:102–109CrossRefPubMed Xu H, Xie JX, Li X et al (2008) Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model. J Magn Reson Imaging 27:102–109CrossRefPubMed
30.
Zurück zum Zitat Wang H, Van de Putte M, Chen F et al (2008) Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology. Eur Radiol 18:1422–1430CrossRefPubMed Wang H, Van de Putte M, Chen F et al (2008) Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology. Eur Radiol 18:1422–1430CrossRefPubMed
31.
Zurück zum Zitat Zhu AX, Sahani DV, Duda DG et al (2009) Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol 27:3027–3035CrossRefPubMedPubMedCentral Zhu AX, Sahani DV, Duda DG et al (2009) Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol 27:3027–3035CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yopp AC, Schwartz LH, Kemeny N et al (2011) Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Ann Surg Oncol 18:2192–2199CrossRefPubMedPubMedCentral Yopp AC, Schwartz LH, Kemeny N et al (2011) Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Ann Surg Oncol 18:2192–2199CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Walker-Samuel S, Leach MO, Collins DJ (2006) Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 51:3593–3602CrossRefPubMed Walker-Samuel S, Leach MO, Collins DJ (2006) Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 51:3593–3602CrossRefPubMed
34.
Zurück zum Zitat Koh TS, Thng CH, Hartono S et al (2011) A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed 24:1169–1180CrossRefPubMed Koh TS, Thng CH, Hartono S et al (2011) A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed 24:1169–1180CrossRefPubMed
Metadaten
Titel
Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model
verfasst von
Wei Zhang
Hui Juan Chen
Zhen J. Wang
Wei Huang
Long Jiang Zhang
Publikationsdatum
03.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4505-1

Weitere Artikel der Ausgabe 5/2017

European Radiology 5/2017 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.